Overview

Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology not only examines the evidence for treating mental health disorders in younger patients but also illuminates how clinical trials of various methodologies can inform different aspects of clinical practice. Organized by DSM-5-TR diagnosis rather than drug class, this clinically accessible volume offers an exhaustive analysis of the use of psychotropic agents in disorders that include • Attention-deficit/hyperactivity disorder • Depressive disorders • Autism spectrum disorder • Early schizophrenia and psychotic illnesses • Eating disorders Comprehensive medication tables allow for easy reference of dosing, side effects, and tips for management. Additionally, key points at the conclusion of each chapter summarize essential information for treating clinicians. With a depth of information unmatched by any other guide, this new edition of the Clinical Manual of Child and Adolescent Psychopharmacology is an indispensable desktop reference for clinicians working with young patients.

Full Product Details

9781615374892

Table of Contents

Reviews

Author Information

Molly McVoy, M.D., is an Associate Professor in psychiatry in the division of Child and Adolescent Psychiatry Fellowship at University Hospitals/Case Western Reserve University in Cleveland, Ohio. Ekaterina Stepanova, M.D, Ph.D., is Chair of Child and Adolescent Psychiatry at Virginia Treatment Center for Children in Richmond, Virginia. Robert L. Findling, M.D., M.B.A., is Chair of the Department of Psychiatry at Virginia Commonwealth University in Richmond, Virginia.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available